Dr. Dieter Braun

Head of Hospital and Complex Generics

Develop global partner network to successfully launch, commercialize and establish appropriate go to market models for biosimilars Licensing in/ out agreements Establish a strong and long-term partnerships worldwide Create win-win business solutions in regions/ countries Member of core management team to develop and commercialize of biosimilars

Leading commercial operations in EUMEA, LATAM, CEE; Enhancing operating excellence across regions; Global product launches; Global launch of line extensions; Developing multiple sales strategies: Management of tender and institutional sales across regions; Regional FTE and P&L responsibility, Management of countries - and global distribution network

Member of executive board; Regional P&L responsibility (LATAM, APAC, META, CEE); Area sales development; Building up commercial excellence for biosimilars; Regional tender management; Global launch and country rollout;

Area sales responsibility (Nordics, Benelux, DACH, CEE, APAC); Evaluation, assessment and implementation of country-specific biosimilar business cases; Establishing of a global pricing strategy for cross country reference pricing and determining of launch sequence/ priorities for biosimilar launches Defining commercial strategy in biosimilar development teams

Facilitating global launch of Omnitrope/ Granditropin and line extensions in RoW; Developing and launch preparation of go to market models; Elaborating country business cases for launch - and market access scenarios

Responsible for sales in Germany; Launch of hGH in RoW; Preparation of biosimilar launches; Member of biosimilar development teams

Launch of Growth Hormone in Germany, Austria, Italy, Spain, France, Nordics; Medical Device Development; International Sales Force Training, Development of global launch and brand plan

Conduct & mionitoring of an international, multicentre clinical trial phIII; Site assessment, initiation and monitoring; CRO management

Scientist; International drug development projetcs; microbial high throughput screening; drug discovery

Drug Discovery

Mikrobiologie, Biotechnologie, Genetik